Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Gut microbial metabolism of 5-ASA diminishes its clinical efficacy in inflammatory bowel disease
Raaj S. Mehta, Jared R. Mayers, Yancong Zhang, et al.
Nature Medicine (2023) Vol. 29, Iss. 3, pp. 700-709
Open Access | Times Cited: 79

Showing 1-25 of 79 citing articles:

Probiotics, prebiotics, and postbiotics in health and disease
Jing Ji, Weilin Jin, Shuang‐Jiang Liu, et al.
MedComm (2023) Vol. 4, Iss. 6
Open Access | Times Cited: 144
Linking microbial genes to plasma and stool metabolites uncovers host-microbial interactions underlying ulcerative colitis disease course
Melanie Schirmer, Martin Stražar, Julián Ávila-Pacheco, et al.
Cell Host & Microbe (2024) Vol. 32, Iss. 2, pp. 209-226.e7
Closed Access | Times Cited: 34
The gut ileal mucosal virome is disturbed in patients with Crohn’s disease and exacerbates intestinal inflammation in mice
Zhirui Cao, Dejun Fan, Yang Sun, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 18
Topical drug delivery strategies for enhancing drug effectiveness by skin barriers, drug delivery systems and individualized dosing
Lin Zhao, Jia‐Mei Chen, Bai Bai, et al.
Frontiers in Pharmacology (2024) Vol. 14
Open Access | Times Cited: 17
Microbiota in inflammatory bowel disease: mechanisms of disease and therapeutic opportunities
Iliyan D. Iliev, Ashwin N. Ananthakrishnan, Chun‐Jun Guo
Nature Reviews Microbiology (2025)
Closed Access | Times Cited: 3
Manipulating Microbiota in Inflammatory Bowel Disease Treatment: Clinical and Natural Product Interventions Explored
Mengjie Zhu, Yijie Song, Yu Xu, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 13, pp. 11004-11004
Open Access | Times Cited: 26
Challenges and opportunities in sharing microbiome data and analyses
Curtis Huttenhower, ROBERT FINN, Alice C. McHardy
Nature Microbiology (2023) Vol. 8, Iss. 11, pp. 1960-1970
Open Access | Times Cited: 25
International consensus statement on microbiome testing in clinical practice
Serena Porcari, Benjamin H. Mullish, Francesco Asnicar, et al.
˜The œLancet. Gastroenterology & hepatology (2024) Vol. 10, Iss. 2, pp. 154-167
Closed Access | Times Cited: 14
Challenges in IBD Research 2024: Precision Medicine
Sana Syed, Brigid S. Boland, Lauren T Bourke, et al.
Inflammatory Bowel Diseases (2024) Vol. 30, Iss. Supplement_2, pp. S39-S54
Open Access | Times Cited: 10
Tethering pH-Induced Structural Modifications of Ovomucin to Stabilize W1/O/W2 Double Emulsions for Enhanced Protection of Companilactobacillus crustorum MN047
Bei Sun, Yang Liu, Rui Sun, et al.
Food Hydrocolloids (2025) Vol. 163, pp. 111060-111060
Closed Access | Times Cited: 1
Ginseng-derived nanocellulose alleviates murine colitis through modulation of inflammation, epithelial barrier and gut microbiome
Yali Liu, Zhengwei Zhang, Shanmin Tao, et al.
Chemical Engineering Journal (2025) Vol. 506, pp. 160254-160254
Closed Access | Times Cited: 1
Designing a microbial fermentation-functionalized alginate microsphere for targeted release of 5-ASA using nano dietary fiber carrier for inflammatory bowel disease treatment
Lei Qiu, Renbin Shen, Lei Wei, et al.
Journal of Nanobiotechnology (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 21
Autophagy: A potential target for natural products in the treatment of ulcerative colitis
Wei Zhang, Menglong Zou, Jia Fu, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 176, pp. 116891-116891
Open Access | Times Cited: 8
Mucoadhesive Mesalamine Prodrug Nanoassemblies to Target Intestinal Macrophages for the Treatment of Inflammatory Bowel Disease
Byeongmin Park, Geonhee Han, Do Young Jin, et al.
ACS Nano (2024) Vol. 18, Iss. 25, pp. 16297-16311
Closed Access | Times Cited: 8
Integrating multi-omics to unravel host-microbiome interactions in inflammatory bowel disease
Yiran Zhang, John P. Thomas, Tamás Korcsmáros, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 9, pp. 101738-101738
Open Access | Times Cited: 8
The gut microbiome regulates the clinical efficacy of sulfasalazine therapy for IBD-associated spondyloarthritis
Svetlana Lima, Sílvia Pires, Amanda Rupert, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 3, pp. 101431-101431
Open Access | Times Cited: 7
Intestinal microbiota by angiotensin receptor blocker therapy exerts protective effects against hypertensive damages
Jing Li, Siyuan Wang, Kaixin Yan, et al.
iMeta (2024) Vol. 3, Iss. 4
Open Access | Times Cited: 7
Copper–luteolin nanocomplexes for Mediating multifaceted regulation of oxidative stress, intestinal barrier, and gut microbiota in inflammatory bowel disease
Wanyue Fu, Zhongshi Huang, Weiqi Li, et al.
Bioactive Materials (2024) Vol. 46, pp. 118-133
Open Access | Times Cited: 6
Advances in the integration of metabolomics and metagenomics for human gut microbiome and their clinical applications
Francesc Puig‐Castellví, Romina Pacheco‐Tapia, Maxime Deslande, et al.
TrAC Trends in Analytical Chemistry (2023) Vol. 167, pp. 117248-117248
Open Access | Times Cited: 16
Microbiome metabolite quantification methods enabling insights into human health and disease
Jarrod Roach, Rohit Mital, Jacob J. Haffner, et al.
Methods (2024) Vol. 222, pp. 81-99
Open Access | Times Cited: 5
Challenges in IBD Research 2024: Preclinical Human IBD Mechanisms
Matthew A. Ciorba, Liza Konnikova, Simon A. Hirota, et al.
Inflammatory Bowel Diseases (2024) Vol. 30, Iss. Supplement_2, pp. S5-S18
Open Access | Times Cited: 5
Gut Microbiome Integration in Drug Discovery and Development of Small Molecules
Patrick Jimonet, Céline Druart, Stéphanie Blanquet‐Diot, et al.
Drug Metabolism and Disposition (2024) Vol. 52, Iss. 4, pp. 274-287
Open Access | Times Cited: 4
Explainable AI-prioritized plasma and fecal metabolites in inflammatory bowel disease and their dietary associations
Serena Onwuka, Laura Bravo-Merodio, Georgios V. Gkoutos, et al.
iScience (2024) Vol. 27, Iss. 7, pp. 110298-110298
Open Access | Times Cited: 4
Whole-cell synthesis of nicotinamide mononucleotide by recombinant Saccharomyces cerevisiae from glucose and nicotinamide
Chaoguang Wang, Xiaohan Hui, George Marshall, et al.
Biochemical Engineering Journal (2024) Vol. 212, pp. 109528-109528
Closed Access | Times Cited: 4
Metatranscriptomics-guided discovery and characterization of a polyphenol-metabolizing gut microbial enzyme
Minwoo Bae, Chi Hieu Le, Raaj S. Mehta, et al.
Cell Host & Microbe (2024)
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top